News | Los Angeles Times

New Tax-Inversion Rules Kill Proposed Allergan-Pfizer Merger

April 6, 2016

Ken Serwin comments on new federal rules to deter corporate inversions by companies shifting their headquarters out of the United States for tax advantages.

Read the article.


Related Professionals

Kenneth Serwin

Managing Director

San Francisco Bay Area